Percutaneous Hepatic Perfusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Percutaneous Hepatic Perfusion, covering 2022-03-24 to 2022-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma [Phase 2, Phase 3]